As of 2024-12-12, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (158.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -309.0%.
The range of the Relative Valuation is (128.88) - (141.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 34.7x | 26.5x |
| Forward P/E multiples | 18.7x - 20.5x | 19.6x |
| Fair Price | (128.88) - (141.29) | (158.86) |
| Upside | -269.6% - -285.9% | -309.0% |
| Date | P/E |